Summary
This prediction ended on 24.10.22 with a price of €0.64. Massive losses of -93.82% were the result for the BUY prediction by BiotechBee. BiotechBee has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tricida | - | - | - | - |
| iShares Core DAX® | 0,99 % | 8,31 % | 7,03 % | 49,79 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % | 35,95 % | 96,63 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % | 46,57 % | 69,05 % |
| iShares S&P 500 | 1,04 % | 11,08 % | 26,46 % | 68,09 % |
According to BiotechBee what are the pros and cons of Tricida for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tricida diskutieren
Buy mit Kursziel 25,0